Polycystic Ovary Syndrome (PCOS) and COVID-19: An Overlooked Female Patient Population at Potentially Higher Risk During the COVID-19 Pandemic

    July 2020 in “ BMC Medicine ”
    Ioannis Kyrou, Emmanouíl Karteris, Tim Robbins, Kamaljit Chatha, Fotios Drenos, Harpal Randeva
    TLDR Women with PCOS may be at higher risk for severe COVID-19.
    The document discussed the increased risk of severe COVID-19 outcomes in women with polycystic ovary syndrome (PCOS) due to overlapping risk factors such as hyper-inflammation, low vitamin D levels, hyperandrogenism, and a high prevalence of cardio-metabolic conditions like type 2 diabetes, obesity, and hypertension. These factors were known to exacerbate COVID-19 outcomes. The paper emphasized the importance of maintaining high standards of care for women with PCOS during the pandemic and the need for comprehensive information and management strategies to address their unique risks. It also highlighted the potential for increased mental health issues and thrombotic risks, and the necessity for closer monitoring of pregnant women with PCOS. The document called for comprehensive care and informed guidance to mitigate COVID-19 risks and ensure optimal management during the pandemic.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results

    Related Community Posts Join

    6 / 21 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 1 year ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Sugar and Hair loss connections

      in Research/Science  41 upvotes 7 months ago
      High sugar diets may worsen hair loss by increasing 5α-reductase activity and androgen levels, especially in women with PCOS. A low sugar diet might reduce scalp DHT levels, similar to finasteride, but genetics also significantly influence hair loss.

      community C’est terrible - at my wits end

      in Female  450 upvotes 2 years ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

    Related Research

    6 / 6 results